The research compared 35 studies that tracked men and women’s persistent COVID-19 symptoms between December 2019 and May 31, 2021, before vaccines were widely available.
Of the 1,393,355 study participants, female patients were more likely than male patients to experience depression; ear, nose, or throat; musculoskeletal; and respiratory symptoms. Men were more likely to experience acute kidney injury.
Women also were more likely to have dermatological, gastrointestinal and neurological long COVID-19 symptoms.
The article’s authors wrote that “the size of female cohorts and sex-disaggregated data analysis and reporting are insufficient in medical research” and said further studies tracking long COVID-19 should report differences among sexes.
Researchers are continuing to evaluate the potential causes of long COVID-19, including probes into the possibility of a perpetual virus, blood vessel damage and the immune system struggling to bounce back.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
